Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and has killed millions to date. Studies are being carried out to find therapeutic molecules that …
Background: The recent outbreak of novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2 has posed a tremendous threat to mankind. The unavailability of a …
N Khamto, K Utama, S Tateing… - Journal of Chemical …, 2023 - ACS Publications
The emergence of SARS-CoV-2 in December 2019 has become a global issue due to the continuous upsurge in patients and the lack of drug efficacy for treatment. SARS-CoV-2 …
D Kashyap, S Jakhmola, D Tiwari… - Journal of …, 2022 - Taylor & Francis
Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially …
Coronavirus disease 2019 (COVID-19) pandemic has infected billions and has killed millions of people. Despite the advancement in drugs and vaccines, the COVID-19 …
Spike glycoprotein, a class I fusion protein harboring the surface of SARS-CoV-2 (SARS- CoV-2S), plays a seminal role in the viral infection starting from recognition of the host cell …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for the current global pandemic that has caused a death toll of> 1.12 million worldwide and …
At the health emergence, no such potent prophylactic therapy is available to control the deadly emerged Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) …
Simple Summary The ongoing coronavirus disease-2019 (COVID-19) pandemic shows unprecedented challenges for the worldwide healthcare system. Despite the large clinical …